Journal
EUROPEAN JOURNAL OF DERMATOLOGY
Volume 25, Issue 4, Pages 296-311Publisher
JOHN LIBBEY EUROTEXT LTD
DOI: 10.1684/ejd.2015.2570
Keywords
5-aminolaevulinic acid; dermatology; guidelines; methyl aminolaevulinate; non-melanoma skin cancer; photodynamic therapy
Categories
Ask authors/readers for more resources
Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, squamous cell carcinoma in-situ, superficial and certain thin basal cell carcinomas. Recurrence rates are typically equivalent to existing therapies, although inferior to surgery for nodular basal cell carcinoma. PDT can be used both as a lesional or as a field therapy and has the potential to delay/reduce the development of new lesions. PDT has also been studied for its place in the treatment of, as well as its potential to prevent, superficial skin cancers in immune-suppressed patients, although sustained clearance rates are lower than for immunocompetent individuals. Many additional indications have been evaluated, including photo-rejuvenation and inflammatory and infective dermatoses. This S2 guideline considers all current and emerging indications for the use of topical photodynamic therapy in Dermatology, prepared by the PDT subgroup of the European Dermatology Forum guidelines committee. It presents consensual expert recommendations reflecting current published evidence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available